PHAXIAM Therapeutics S.A. Issued Capital
PHAXIAM Therapeutics S.A. had Issued Capital of EUR 6.08 million as of 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes
ifrs-full:IssuedCapital · last filed 2023-09-26
- 2023-06-30: Issued Capital 6.08M EUR.
- 2022-12-31: Issued Capital 3.10M EUR.
- 2022-06-30: Issued Capital 3.10M EUR.
- 2021-12-31: Issued Capital 3.10M EUR.
| Period end | Issued Capital |
|---|---|
| 2023-06-30 | 6.08M EUR 6-K · filed 2023-09-26 |
| 2022-12-31 | 3.10M EUR 6-K · filed 2023-09-26 |
| 2022-06-30 | 3.10M EUR 6-K · filed 2022-09-12 |
| 2021-12-31 | 3.10M EUR 20-F · filed 2023-03-28 |
| 2021-06-30 | 2.64M EUR 6-K · filed 2021-09-20 |
| 2020-12-31 | 2.01M EUR 20-F · filed 2023-03-28 |
| 2020-06-30 | 1.80M EUR 6-K · filed 2020-09-21 |
| 2019-12-31 | 1.79M EUR 20-F · filed 2022-04-27 |
| 2019-06-30 | 1.79M EUR 6-K · filed 2019-09-26 |
| 2018-12-31 | 1.79M EUR 20-F · filed 2021-03-08 |
| 2017-12-31 | 1.79M EUR 20-F · filed 2020-03-18 |
| 2016-12-31 | 873.00K EUR 20-F · filed 2019-03-29 |
| 2015-12-31 | 792.00K EUR 20-F/A · filed 2018-05-23 |